Welcome to the Oncomine Blog

Shifting the Paradigm: Broader Patient Access to Personalized Oncology Treatments Hinges on In-House Comprehensive Genomic Testing


We are living in an unprecedented time in the collective fight against cancer, where recent developments in drug development are giving rise to a new era of hope.  In 2018, the U.S. Food and Drug Administration (FDA) approved 59 novel therapies,..

The Importance of Detecting the Most Fusions ...

In recent years, we’ve seen an increasing number of new therapies emerge that target gene fusions ...

Stay Up-To-Date

Connect project to a Slack channel and everyone in the team will be notified